Reaction: 5-hydroxytegafur to 1 product

Reaction
5-hydroxytegafur
DBMET00753
    5-fluorouracil
    DBMET00449
    Reaction type
    hydrolysis; oxidation
    Direction
    Major circulating metabolite?
    Yes
    Spontaneous?
    No
    Activity
    active
    References
    1. Timmers L, Swart EL, Boons CC, Mangnus D, van de Ven PM, Peters GJ, Boven E, Hugtenburg JG: The use of capecitabine in daily practice: a study on adherence and patients' experiences. Patient Prefer Adherence. 2012;6:741-8. doi: 10.2147/PPA.S36757. Epub 2012 Oct 19. [Article]
    2. UFT (uracil/tegafur) capsules_Product information [Link]
    Comments
    Not Available
    Enzymes
    Not Available